Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical Chemistry

• Publication date

  2004-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1373/CLINCHEM.2004.034272PMID 15265821
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• B‐type natriuretic peptide and its precursor in cardiac venous blood from failing hearts

  2005cited by this paper
• The natriuretic peptides

  2004cited by this paper
• Diagnosis of heart failure using urinary natriuretic peptides.

  2004cited by this paper
• Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review.

  2004cited by this paper
• Cardiac natriuretic peptides:a proteomic window to cardiac function and clinical management.

  2003cited by this paper
• B-type natriuretic peptide in ischemic heart disease

  2003cited by this paper
• Clinical applications of B-type natriuretic peptide (BNP) testing.

  2003cited by this paper
• B-type natriuretic peptide in cardiovascular disease.

  2003cited by this paper
• Functional Analysis of the Transmembrane Domain and Activation Cleavage of Human Corin

  2003cited by this paper
• BNP as discharge criteria for heart failure.

  2003cited by this paper
• NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function

  2003cited by this paper
• Characterization of molecular forms of probrain natriuretic peptide in human plasma.

  2003cited by this paper
• The posttranslational phase of gene expression: new possibilities in molecular diagnosis.

  2003cited by this paper
• Cardiac hormones as diagnostic tools in heart failure.

  2003cited by this paper
• Plasma Brain Natriuretic Peptide Levels and Blood Pressure Tracking in the Framingham Heart Study

  2003cited by this paper
• The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure?

  2003cited by this paper
• Use of BNP Levels in Monitoring Hospitalized Heart Failure Patients with Heart Failure

  2003cited by this paper
• Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure.

  2003cited by this paper
• The Role of Brain Natriuretic Peptide in Population Screening

  2003cited by this paper
• Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease

  2003cited by this paper
• Furin-mediated Processing of Pro-C-type Natriuretic Peptide*

  2003cited by this paper
• The Diagnosis of Acute Congestive Heart Failure: Role of BNP Measurements

  2003cited by this paper
• B-type natriuretic peptides: a diagnostic breakthrough for clinicians.

  2003cited by this paper
• The posttranslational phase of gene expression: new possibilities in molecular diagnosis.

  2003cited by this paper
• Natriuretic Peptide System Gene Expression in Human Coronary Arteries

  2002cited by this paper
• Quantification of pro-B-type natriuretic peptide and its products in human plasma by use of an analysis independent of precursor processing.

  2002influential reference
• Processing of Pro-atrial Natriuretic Peptide by Corin in Cardiac Myocytes*

  2002cited by this paper
• Chamber-Dependent Expression of Brain Natriuretic Peptide and Its mRNA in Normal and Diabetic Pig Heart

  2002cited by this paper
• Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases

  2002cited by this paper
• Molecular forms of human brain natriuretic peptide in plasma.

  2002cited by this paper
• The pregnancy hormone relaxin is a player in human heart failure

  2001cited by this paper
• Radioimmunoassay for N-terminal probrain natriuretic peptide in human plasma

  2001cited by this paper
• The physiological and pathophysiological modulation of the endocrine function of the heart.

  2001cited by this paper
• Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme.

  2000cited by this paper
• Vesicular Localization and Characterization of a Novel Post-Proline-Cleaving Aminodipeptidase, Quiescent Cell Proline Dipeptidase1

  2000cited by this paper
• Localization of the mosaic transmembrane serine protease corin to heart myocytes.

  2000cited by this paper
• Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase.

  2000cited by this paper
• FEBS Lett

  2000cited by this paper
• Deconvolution Analysis of Cardiac Natriuretic Peptides During Acute Volume Overload

  2000cited by this paper
• Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit.

  1999cited by this paper
• Corin, a Mosaic Transmembrane Serine Protease Encoded by a Novel cDNA from Human Heart*

  1999cited by this paper
• Sequence, Purification, and Cloning of an Intracellular Serine Protease, Quiescent Cell Proline Dipeptidase*

  1999cited by this paper
• The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs.

  1999cited by this paper
• Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.

  1998cited by this paper
• Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis.

  1998cited by this paper
• Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure.

  1998cited by this paper
• The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32.

  1997cited by this paper
• Stretch-induced Hypertrophic Growth of Cardiocytes and Processing of Brain-type Natriuretic Peptide Are Controlled by Proprotein-processing Endoprotease Furin*

  1997cited by this paper
• Adenovirally encoded prohormone convertase-1 functions in atrial myocyte large dense core vesicles.

  1997cited by this paper
• Electronmicroscopic observations regarding the presence of natriuretic granules in the ventricle of patients with cardiopathies.

  1997cited by this paper
• Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairment

  1997cited by this paper
• Co‐elevation of brain natriuretic peptide and proprotein‐processing endoprotease furin after myocardial infarction in rats

  1997cited by this paper
• Urinary immunoreactive brain natriuretic peptide in patients with renal disease.

  1996cited by this paper
• The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma.

  1995influential reference
• The distinct gene expression of the pro-hormone convertases in the rat heart suggests potential substrates

  1995cited by this paper
• Dissociation of cardiac hypertrophy, myosin heavy chain isoform expression, and natriuretic peptide production in DOCA-salt rats.

  1995cited by this paper
• Proline motifs in peptides and their biological processing

  1995cited by this paper
• Structure, expression, and genomic mapping of the mouse natriuretic peptide type-B gene.

  1993cited by this paper
• Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies.

  1993cited by this paper
• Brain natriuretic peptide: natriuretic and endocrine effects in essential hypertension

  1993cited by this paper
• The role of the C‐terminal region of rat brain natriuretic peptide in receptor selectivity

  1992cited by this paper
• Prohormone-converting enzymes: regulation and evaluation of function using antisense RNA.

  1991cited by this paper
• Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

  1991cited by this paper
• Increased human brain natriuretic peptide in congestive heart failure.

  1990cited by this paper
• Isolation and sequence determination of human brain natriuretic peptide in human atrium

  1990cited by this paper
• Human brain natriuretic peptide, a novel cardiac hormone.

  1990cited by this paper
• Concentrations of N-terminal ProANP in human plasma: evidence for ProANP (1-98) as the circulating form.

  1990cited by this paper
• C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.

  1990cited by this paper
• Human brain natriuretic peptide, a novel cardiac hormone

  1990cited by this paper
• Isolation and identification of human brain natriuretic peptides in cardiac atrium.

  1990cited by this paper
• Brain natriuretic peptide is a novel cardiac hormone.

  1989cited by this paper
• Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide.

  1989cited by this paper
• Isolation and identification of rat brain natriuretic peptides in cardiac atrium.

  1989cited by this paper
• Cloning of a cDNA encoding porcine brain natriuretic peptide.

  1989cited by this paper
• Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide.

  1989cited by this paper
• Cloning and sequence analysis of cDNA encoding a precursor for porcine brain natriuretic peptide.

  1988cited by this paper
• A new natriuretic peptide in porcine brain

  1988cited by this paper
• Cloning and sequence analysis of cDNA encoding a precursor for porcine brain natriuretic peptide

  1988cited by this paper
• The presence of brain natriuretic peptide of 12,000 daltons in porcine heart.

  1988cited by this paper
• Atrial natriuretic peptide elevation in congestive heart failure in the human.

  1986cited by this paper
• Cardionatrin I - a novel heart peptide with potent diuretic and natriuretic properties.

  1983cited by this paper
• The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties.

  1983cited by this paper
• A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

  1981cited by this paper
• Comparison of X-prolyl dipeptidyl-aminopeptidase activity in human cerebrospinal fluid with that in serum

  1979cited by this paper
• X-Prolyl dipeptidyl-aminopeptidase activity, with X-proline p-nitroanilides as substrates, in normal and pathological human sera.

  1976cited by this paper
• SPECIFIC GRANULES IN ATRIAL MUSCLE CELLS

  1964cited by this paper
• A SGINIFICANT ELECTRON MICROSCOPIC DIFFERENCE BETWEEN THE ATRIA AND THE VENTRICLES OF THE MAMMALIAN HEART.

  1963cited by this paper

• Pathophysiological mechanisms of integrated regulation of water-sodium homeostasis: from cellular dysfunction of Na-K-ATPase to dysregulation of systemic volume control: a systematic review

  2025cites this paper
• Emerging Electrochemical and Biosensing Platforms for Troponin I and B-Type Natriuretic Peptide: A Comprehensive Insight into Next-Generation Cardiac Diagnostics.

  2025cites this paper
• The Role of N-Terminal-Pro-B-Type Natriuretic Peptide (NT-proBNP) and High-Sensitivity Troponin T (Hs-Troponin T) in the Evaluation of the Syntax Score in Patients With Acute Coronary Syndrome

  2024cites this paper
• A Brief Report on Utility of N-terminal pro-B-type Natriuretic Peptide (NT-proBNP) in Screening Patients at Risk of Atrial Fibrillation and Stroke

  2023cites this paper
• Functional Assessment

  2022cites this paper
• Blood parameters as a measure for controlling physical performance of young Algerian cyclists (U23 category)

  2021cites this paper
• The role of NT-proBNP in the diagnosis of diastolic heart failure and its correlation with echocardiography

  2021cites this paper
• BNP and NT-proBNP Interpretation in the Neprilysin Inhibitor Era

  2020cites this paper
• B-Type Natriuretic Peptide as a Significant Brain Biomarker for Stroke Triaging Using a Bedside Point-of-Care Monitoring Biosensor

  2020cites this paper
• The therapeutic effect of B‐type natriuretic peptides in acute decompensated heart failure

  2020cites this paper
• Identifying Cardiac Diseases using Cardiac Biomarkers in Rhesus Macaques (Macaca mulatta).

  2020cites this paper
• Combined determination of B-type natriuretic peptide and high-sensitivity troponin I in the postmortem diagnosis of cardiac disease

  2019cites this paper
• Right ventricular dysfunction is superior and sufficient for risk stratification by a pulmonary embolism response team

  2019cites this paper
• Diagnostic methods for the canine idiopathic dilated cardiomyopathy: A narrative evidence-based rapid review.

  2019cites this paper
• Categorical Assignment of Pulmonary Embolism is a Simple and More Accurate Indicator of Right Ventricular Dysfunction and Short Team Mortality

  2019cites this paper
• Future Considerations in Nocturia and Nocturnal Polyuria.

  2019cites this paper
• Analytical barriers in clinical B-type natriuretic peptide measurement and the promising analytical methods based on mass spectrometry technology

  2018cites this paper
• Doxorubicin-Induced Cardiotoxicity

  2018cites this paper
• A CLINICAL STUDY OF N-TERMINAL PRO-BNP LEVELS IN CONGESTIVE HEART FAILURE

  2017cites this paper
• Investigation of an N‐Terminal Prohormone of Brain Natriuretic Peptide Point‐of‐Care ELISA in Clinically Normal Cats and Cats With Cardiac Disease

  2017cites this paper
• Natriuretic peptides: degradation, circulating forms, dosages and new therapeutic approaches.

  2017cites this paper
• Association between Survival Time and Changes in NT‐proBNP in Cats Treated for Congestive Heart Failure

  2017cites this paper
• A Comparative Perspective on Wnt/β-Catenin Signalling in Cell Fate Determination.

  2017cites this paper
• Feasibility, safety, and tolerance of subcutaneous synthetic canine B-type natriuretic peptide (syncBNP) in healthy dogs and dogs with stage B1 mitral valve disease.

  2017cites this paper
• Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure.

  2017cites this paper
• The Endocrine Heart

  2016cites this paper
• Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.

  2016cites this paper
• N-Terminal Pro-Brain Natriuretic Peptide Level is Associated With Severity and Complexity of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome

  2016cites this paper
• Regulation of B‐type natriuretic peptide synthesis by insulin in obesity in male mice

  2016cites this paper
• B-Type Cardiac Natriuretic Peptides in the Neonatal and Pediatric Intensive Care Units

  2016cites this paper
• Equine BNP measurement using a porcine BNP enzyme-linked immunoassay: a pilot study

  2015cites this paper
• Rola peptydów natriuretycznych w migotaniu przedsionków – aktualny stan wiedzy Clinical significance of natriuretic peptides in patients with atrial fibrillation – current state of knowledge

  2015cites this paper
• State of the art of immunoassay methods for B-type natriuretic peptides: An update

  2015cites this paper
• BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use?

  2015cites this paper
• Angiotensin‐converting enzyme inhibition prevents myocardial infarction‐induced increase in renal cortical cGMP and cAMP phosphodiesterase activities

  2015cites this paper
• Analyse van equine BNP met een porciene BNP "enzyme-linked immunoassay": een pilootstudie

  2015cites this paper
• The application of cardiac biomarkers as detectors for cardiac disease in horses

  2015cites this paper
• C-type natriuretic peptide and its precursor: potential markers in human prostate cancer.

  2015cites this paper
• Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides.

  2015cites this paper
• A multimarker approach to diagnose and stratify heart failure.

  2015cites this paper
• Péptido natriurético tipo B en pacientes con enfermedad de Chagas: utilidad diagnóstica en la insuficiencia cardíaca.

  2014cites this paper
• Péptido natriurético tipo B en pacientes con enfermedad de Chagas: utilidad diagnóstica en la insuficiencia cardíaca

  2014cites this paper
• NT-proBNP for prognostic and diagnostic evaluation in patients with acute coronary syndromes.

  2013cites this paper
• A Sensor of Protein O‐Glycosylation Based on Sequential Processing in the Golgi Apparatus

  2013cites this paper
• B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function

  2013cites this paper
• Recent advances on natriuretic peptide system: new promising therapeutic targets for the treatment of heart failure.

  2013influential citation
• Cardiac function in offspring of women with diabetes using fetal ECG, umbilical cord blood pro-BNP, and neonatal interventricular septal thickness

  2013cites this paper
• Clinical usefulness of an assay for measurement of circulating N-terminal pro-B-type natriuretic peptide concentration in dogs and cats with heart disease.

  2013cites this paper
• Pharmacological modulation of insulin resistance : benefits and harms

  2013cites this paper
• BNP and NT-proBNP levels in patients with sepsis.

  2013cites this paper
• Natriuretic Peptides as Therapy in Cardiac Ischae- mia/Reperfusion

  2012cites this paper
• The use of cardiac biomarkers in veterinary medicine: the equine perspective Diergeneeskundig gebruik van cardiogene biomarkers : focus op het gebruik bij paarden

  2012cites this paper
• Evaluation of plasma N-terminal pro-B-type natriuretic peptide concentrations in dogs with and without cardiac disease.

  2012cites this paper
• Maternal diabetes during pregnancy – obstetrical considerations and long term effects

  2012cites this paper
• B-type natriuretic peptide: from posttranslational processing to clinical measurement.

  2012cites this paper
• IntErés DE los PéPtIDos natrIurétIcos En carDIología VEtErInarIa

  2012cites this paper
• Circulating forms of the b-type natriuretic peptide prohormone: pathophysiologic and clinical considerations.

  2012cites this paper
• Expression of B-type natriuretic peptide forms in ischemic human hearts.

  2012cites this paper
• Effect of heart failure on dipeptidyl peptidase IV activity in plasma of dogs.

  2012cites this paper
• Natriuretic peptides as therapy in cardiac ischaemia/reperfusion.

  2012cites this paper
• ProBNP(1-108) is resistant to degradation and activates guanylyl cyclase-A with reduced potency.

  2011cites this paper
• Granulocyte colony stimulating factor in chronic angina to stimulate neovascularisation: a placebo controlled crossover trial

  2011cites this paper
• Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance

  2011cites this paper
• Stillbirth in diabetic pregnancies.

  2011cites this paper
• Measurement of the total proANP product in mammals by processing independent analysis.

  2011cites this paper
• Risk stratification and short-term prognosis in acute heart failure syndromes: A review of novel biomarkers

  2011cites this paper
• Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.

  2011influential citation
• Article in press-uncorrected proof Minireview Measurement of the prohormone of brain type natriuretic peptide ( proBNP ) : methodological considerations and pathophysiological relevance

  2011cites this paper
• Letter by Goetze et al regarding article, "B-type natriuretic peptide signal peptide circulates in human blood: evaluation as a potential biomarker of cardiac ischemia".

  2011cites this paper
• SPS ABP2 testing - 1

  2011cites this paper
• Understanding cardiac biomarkers in end‐stage kidney disease: Frequently asked questions and the promise of clinical application

  2011cites this paper
• The paradox of low BNP levels in obesity

  2011cites this paper
• Relationships between serum levels of thyroid hormones and serum concentrations of asymmetric dimethylarginine (ADMA) and N-terminal-pro-B-type natriuretic peptide (NT-proBNP) in patients with Graves’ disease

  2011cites this paper
• Assessment of cardiotoxicity with cardiac biomarkers in cancer patients

  2011cites this paper
• Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes.

  2011cites this paper
• Role of biomarkers in cardioncology

  2011cites this paper
• B-type natriuretic peptide secretion following scuba diving.

  2011cites this paper
• Diagnosing Destabilized Heart Failure in the Emergency Setting

  2011cites this paper
• Serum Levels of Adipocyte Fatty Acid-Binding Protein Are Associated with the Severity of Coronary Artery Disease in Chinese Women

  2011cites this paper
• The diagnostic significance of the plasma N-terminal pro-B-type natriuretic Peptide concentration in asymptomatic cats with cardiac enlargement.

  2011cites this paper
• Systemic review of BNP and NT-proBNP levels in diagnosis and response to treatment of patent ductus arteriosus in preterm neonates

  2011cites this paper
• Biomarkers of Myocardial Stress and Systemic Inflammation in Patients Who Engage in Heart Failure Self-care Management

  2011cites this paper
• natriuretic hormones physiological role and clinical utility of cardiac Thirty years of the heart as an endocrine organ

  2011cites this paper
• B-type natriuretic peptide as a marker of heart failure: new insights from biochemistry and clinical implications.

  2010cites this paper
• C-type natriuretic-derived peptides as biomarkers in human disease.

  2010cites this paper
• Characterization of molecular forms of N-terminal B-type natriuretic peptide in vitro.

  2010cites this paper
• Circulating levels of stress associated peptide Urocortin in heart failure patients.

  2010cites this paper
• Clinical applications of N-terminal pro B-type natriuretic peptide in heart failure and other cardiovascular diseases

  2010cites this paper
• Chamber-dependent circadian expression of cardiac natriuretic peptides.

  2010cites this paper
• Effect of sialylated O-glycans in pro-brain natriuretic peptide stability.

  2010cites this paper
• Atrial fibrillation after thoracic surgery for lung cancer: use of a single cut-off value of N-terminal pro-B type natriuretic peptide to identify patients at risk

  2010cites this paper
• Impact of diuretic treatment and sodium intake on plasma volume in patients with compensated systolic heart failure

  2010cites this paper
• Les peptides natriurétiques de type B

  2010cites this paper
• Biosynthesis of cardiac natriuretic peptides.

  2010cites this paper
• Best Practice & Research, Clinical Obstetrics & Gynaecology

  2010cites this paper
• Natriuretic Peptides: Prediction of Cardiovascular Disease in the General Population and High Risk Populations

  2009cites this paper
• Marqueurs biochimiques de l’insuffisance cardiaque (IC)

  2009cites this paper
• Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy.

  2009cites this paper
• Crystal structure and thermodynamic analysis of diagnostic mAb 106.3 complexed with BNP 5‐13 (C10A)

  2009cites this paper
• B-type natriuretic peptides.

  2009cites this paper